TMCnet News
Organovo Holdings, Inc.'s Presentations Now Available for On-Demand Viewing at VirtualInvestorConferences.comCompany invites individual and institutional investors to log-on to VirtualInvestorConferences.com to view presentations SAN DIEGO, March 6, 2015 /PRNewswire/ -- Organovo Holdings, Inc. (NYSE MKT: ONVO; "Organovo"), a three-dimensional biology company focused on delivering breakthrough 3D bioprinting technology, announced today that the March 5th presentation given by President and CEO Keith Murphy is now available for on-demand viewing at VirtualInvestorConferences.com. LINK to the company update presentation: http://virtualinvestorconferences.com > red "register / watch presentations here" button. Organovo's company update presentation will be available 24/7 for 90 days. Investors and advisors may download shareholder materials from the "virtual trade booth" for the next three weeks. For investors not yet familiar with the company and desire background, including an understanding of the 3D bioprinting technology used by Organovo to create functional living human tissues, investors can watch an informational background presentation on the Company's website: http://www.organovo.com/investors/investor-overview. Recent Company Highlights Include:
Organovo designs and creates functional, three-dimensional human tissues for use in medical research and therapeutic applications. The Company develops 3D human disease models through internal development and in collaboration with pharmaceutical and academic partners. Organovo's 3D human tissues have the potential to accelerate the drug discovery process, enabling treatments to be developed faster and at lower cost. The company recently launched its initial product of the planned exVive3DTM portfolio offering, a 3D Human Liver Tissue for use in Toxicology and other preclinical drug testing. Additional products are in development, with anticipated release for an exVive3DTM Human Kidney Tissue in the latter half of calendar year 2016. The Company also actively conducts early research on specific tissues for therapeutic use in direct surgical applications. In addition to numerous scientific publications, the Company's technology has been featured in The Wall Street Journal, Time Magazine, The Economist, and numerous other media outlets. Organovo is changing the shape of medical research and practice. Learn more at www.organovo.com. Sign up for email updates and connect with us on Twitter (@Organovo). About VirtualInvestorConferences.com Designed to replicate the look and feel of location-based investor conferences, Virtual Investor Conferences unites PR Newswire's leading-edge online conferencing and investor communications capabilities with BetterInvesting's extensive retail investor audience network. To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/organovo-holdings-incs-presentations-now-available-for-on-demand-viewing-at-virtualinvestorconferencescom-300046606.html SOURCE Organovo Holdings, Inc. |